Paresh Patel

CEO Paresh Patel purchased 2,000 shares of XZO at $13.67 via 10b5-1 plan; stock down 18.6% in 30 days

Paresh Patel, Chief Executive Officer, purchased 2,000 shares at $13.67 on 2026-05-27 as part of a pre-arranged 10b5-1 trading plan, meaning the transaction was scheduled rather than discretionary. The stock has declined 18.6% over the past 30 days and trades at $13.64, currently -44.6% from its 52-week high of $24.60. Patel's prior five purchases at XZO (spanning 2026-05-15 through 2026-05-20) all showed negative returns in both 30-day and 90-day windows, ranging from -3.0% to -7.2%, establishing a pattern of underwater positions following his recent acquisitions at this ticker. The underlying business shows strength with +62.0% annual revenue growth and a P/E of 14.51, but the repeated accumulation during a sustained decline and the 10b5-1 plan structure indicate this purchase was pre-determined and not responsive to current market conditions.

CEO Paresh Patel bought 2,000 shares of XZO at $13.26 on 2026-05-26 via scheduled 10b5-1 plan; stock down 45.2% from 52-week high.

Paresh Patel purchased 2,000 shares at $13.26 on 2026-05-26 as part of a pre-arranged 10b5-1 trading plan, meaning this purchase was scheduled rather than discretionary. The stock has declined 20.0% over the past 30 days and 15.4% over 90 days, and is currently 45.2% below its 52-week high of $24.60. Patel's same-ticker history at XZO shows five prior trades (two on 2026-05-15, one on 2026-05-18, one on 2026-05-19, and one on 2026-05-20), each resulting in negative 30-day and 90-day returns ranging from -3.0% to -7.2%. His cross-ticker track record across 20 prior buys shows an average 90-day return of -13.9% with a 0.00% win rate, suggesting a pattern of unfavorable post-purchase price performance. Against this backdrop, XZO's fundamentals show revenue of $55,534,000.00 with net income of $20,406,000.00 and annual revenue growth of +62.0%, though the P/E of 14.33 must be weighed against the recent sharp price decline.

CEO Patel buys 2,000 shares of XZO at $12.92 on 2026-05-22 via 10b5-1 plan; stock down -45.2% from 52-week high.

Paresh Patel, CEO of Exzeo Group, purchased 2,000 shares at $12.92 on 2026-05-22 as part of a pre-arranged 10b5-1 trading plan, bringing his holdings to 1,668,013 shares. This transaction is scheduled, not discretionary. The stock has declined -45.2% from its 52-week high of $24.60 and is down -20.0% over the past 30 days. Patel's prior five purchases at XZO (spanning 2026-05-15 through 2026-05-20) have each shown negative returns through both 30-day and 90-day windows, ranging from -3.0% to -7.2%. His cross-ticker buy history across 20 prior trades shows an average 90-day return of -13.9% with a 0.00% win rate. The company's fundamentals remain strong—annual revenue growth of +62.0%, net income of $20,406,000.00, P/E of 14.33, and market cap of $1,224,671,252.10—but the ongoing price weakness and the sequential nature of these purchases during a sustained drawdown warrant attention to whether execution or market conditions underlie the recent performance divergence.

CEO Paresh Patel bought 2,000 XZO shares at $12.82 via scheduled 10b5-1 plan; stock down 47.3% from 52-week high.

Paresh Patel (Chief Executive Officer) purchased 2,000 shares (2.0K shares) of XZO at $12.82 on 2026-05-21, increasing holdings from 1,664,013 to 1,666,013 shares. This acquisition was executed under a pre-arranged 10b5-1 trading plan, meaning it was scheduled rather than discretionary. The transaction occurs in a declining price environment: XZO is trading at $12.97, down 47.3% from its 52-week high of $24.60 and down 22.8% over the prior 30 days. Examining Patel's same-ticker history reveals a pattern of purchases at XZO over consecutive trading days (2026-05-15 through 2026-05-20), all of which showed underwater positions within 30–90 days (ranging from -3.0% to -7.2%). The scheduled nature of the plan, combined with the sustained price decline and the pattern of prior same-ticker trades also remaining underwater, indicates this buy is part of a pre-set schedule rather than a signal of conviction at current valuations.

CEO Paresh Patel buys 2,000 shares of XZO at $13.33 under 10b5-1 plan; stock down 47.4% from 52-week high.

Paresh Patel, Chief Executive Officer, purchased 2,000 shares at $13.33 on 2026-05-20 as part of a pre-arranged 10b5-1 trading plan, bringing holdings to 1,664,013 shares. The current stock price of $12.93 is down 47.4% from the 52-week high of $24.60, and the 30-day price change stands at -22.0%. Examining his prior trades at XZO, five recent purchases between 2026-05-06 and 2026-05-12 showed negative returns: -22.8%, -11.4%, -1.0%, -4.4%, and -3.4% respectively on a 90-day basis. The company reports strong fundamentals with revenue of $55,534,000.00, net income of $20,406,000.00, and annual revenue growth of +62.0%, though the P/E of 13.76 and market cap of $1,175,575,299.90 provide context for valuation. As this transaction is scheduled under a 10b5-1 plan rather than discretionary, it represents a pre-committed execution separate from any real-time market assessment.

CEO Patel buys 2,000 shares at $13.69 under 10b5-1 plan; stock -44.4% from 52-week high, his prior trades here mostly underwater

Patel Paresh, Chief Executive Officer, purchased 2,000 shares at $13.69 on 2026-05-19, adding to holdings of 1,662,013 shares post-transaction. This transaction is part of a pre-arranged 10b5-1 trading plan, meaning it is scheduled rather than discretionary. The stock is currently trading at $13.69, down 44.4% from its 52-week high of $24.60. Examining his same-ticker history at XZO, five prior purchases made since 2026-05-06 have all been negative: returns ranging from -1.0% to -22.8% at the 30- and 90-day marks. Against fundamentals showing $55.5M quarterly revenue, +62.0% annual growth, and a P/E of 14.56, the recurring pattern of underwater purchases at this ticker—combined with a cross-ticker track record showing 0% 90-day win rate across 20 prior buys—suggests systematic execution at predetermined prices rather than discretionary conviction at attractive levels.

CEO Patel Paresh buys 2,000 (2.0K shares) of XZO at $13.93 via scheduled 10b5-1 plan as stock falls 44.4% from 52-week high.

Patel Paresh, CEO of Exzeo Group (XZO), purchased 2,000 shares at $13.93 on 2026-05-18 as part of a pre-arranged 10b5-1 trading plan, bringing his holdings to 1,660,013 shares. The trade occurs while XZO trades at $13.69, down -44.4% from its 52-week high of $24.60 and down -21.8% over the past 30 days. Notably, this represents a scheduled transaction, not a discretionary decision, and prior open-market purchases by this insider have shown a poor pattern: across 20 prior cross-ticker buys, the average 90-day return was -16.7% with a 0.00% win rate. At XZO specifically, the five prior purchases in early May 2026 posted negative returns ranging from -1.0% to -22.8% over 90 days. The company's fundamentals remain solid (62.0% annual revenue growth, net income of $20.4M, P/E of 14.56), but the transaction timing relative to recent price deterioration and the insider's poor purchase-history outcomes provide limited positive signal value for investors.

CEO Paresh Patel buys 2,000 shares for $27,355 via 10b5-1 plan; stock down 44.3% YTD from $24.60 high.

CEO Paresh Patel completed 2 separate purchases totaling 2,000 shares for $27,355.00 at blended average price $13.68 on 2026-05-15, increasing his holdings from 1,656,013 to 1,658,013 shares. However, this purchase is executed under a pre-arranged 10b5-1 trading plan, meaning it is scheduled rather than discretionary. The stock has declined 44.3% from its 52-week high of $24.60 to current price $13.71, and fallen 21.7% over the past 30 days. Examining Patel's prior trades at XZO over the 5 preceding days (2026-05-06 through 2026-05-12), all resulted in negative returns at both 30-day and 90-day horizons, ranging from -1.0% to -22.8%, suggesting the recent downtrend has persisted across multiple scheduled purchases. The underlying business shows strength—revenue of $55,534,000.00 with net income of $20,406,000.00 and 62.0% annual revenue growth—yet the stock's sustained decline and the 10b5-1 scheduling framework prevent attribution of this purchase to any tactical conviction or timing insight by the CEO.

CEO Patel purchases 2,000 XZO shares at $13.75 under 10b5-1 plan; stock at $13.56, down 44.9% from 52-week high.

Patel Paresh (CEO) executed a 2,000-share purchase on 2026-05-14 at $13.75, adding to holdings now at 1.66M shares, under a pre-arranged 10b5-1 trading plan. The stock currently trades at $13.56, representing a 44.9% decline from the 52-week high of $24.60, a 19.2% drop over 30 days, and a 12.0% decline over 90 days. The company's fundamentals include $55.5M quarterly revenue, $20.4M net income, 62.0% annual revenue growth, a P/E of 14.43, and market cap of $1.2B. Because this transaction is scheduled under a 10b5-1 plan rather than discretionary, the purchase reflects a pre-committed execution rather than a market-timing decision by the executive.

CEO Patel Paresh buys 2,000 XZO shares at $13.55 under 10b5-1 plan; stock down 45.0% from 52-week high, 0/5 prior buys well-timed.

Patel Paresh, CEO of Exzeo Group, acquired 2,000 shares at $13.55 on 2026-05-13 as part of a pre-arranged 10b5-1 trading plan, not a discretionary decision. The transaction occurs amid significant price weakness: the stock is trading -45.0% from its 52-week high of $24.60, and down -16.4% over the prior 30 days. However, this scheduled plan removes any inference about insider conviction regarding current valuation. More tellingly, Patel's prior five consecutive purchases at XZO (2026-05-06 through 2026-05-12) show a 0% win rate at the 90-day horizon, with the most recent buy on 2026-05-12 already underwater by -3.4%. This pattern of systematically poor timing across five rapid consecutive buys—especially the 2026-05-06 purchase down -22.8% at 90 days—suggests the 10b5-1 plan is mechanically executing regardless of market conditions. While Exzeo's fundamentals remain solid (revenue $55.5M, net income $20.4M, +62.0% annual growth, P/E 14.39), the absence of positive entry signals from the insider's own prior trades at this ticker undermines confidence in this buy's timing.